The Efficacy and Safety of Combined Teriflunomide and High-dose Dexamethasone in Newly Diagnosed Primary Immune Thrombocytopenia (TEMPO-2) — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(3 sites)
China
Peking University First Hospital, Beijing, Beijing Municipality Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing Municipality Peking University Third Hospital, Beijing, Beijing Municipality Age range
18 Years and older
Last updated September 2025